201 related articles for article (PubMed ID: 6258196)
21. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
Eggerman TL; Harker LA; Andersen NH; Wilson CH
Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
[No Abstract] [Full Text] [Related]
22. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin.
Beretz A; Stierle A; Anton R; Cazenave JP
Biochem Pharmacol; 1982 Nov; 31(22):3597-600. PubMed ID: 6295405
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of ZK 36374, a stable prostacyclin analogue, on adhesion of rabbit platelets to damaged aorta and serotonin release by adherent platelets.
Menys VC; Davies JA
Clin Sci (Lond); 1983 Aug; 65(2):149-53. PubMed ID: 6190604
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of platelet factor 3 availability by prostacyclin.
Hársfalvi J; Muszbek L; Stadler I; Fésüs L
Prostaglandins; 1980 Nov; 20(5):935-45. PubMed ID: 7008092
[TBL] [Abstract][Full Text] [Related]
25. A biphasic effect of prostacyclin (PGI2) on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Thromb Res; 1980 Sep; 19(6):877-81. PubMed ID: 6258262
[No Abstract] [Full Text] [Related]
26. De-aggregatory action of prostacyclin in vivo and its enhancement by theophylline.
Gryglewski RJ; Korbut R; Ocetkiewicz A
Prostaglandins; 1978 Apr; 15(4):637-44. PubMed ID: 353903
[TBL] [Abstract][Full Text] [Related]
27. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
[No Abstract] [Full Text] [Related]
28. Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets.
Hawiger J; Parkinson S; Timmons S
Nature; 1980 Jan; 283(5743):195-7. PubMed ID: 6985716
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating-factor (PAF) in the rabbit.
Camussi G; Tetta C; Bussolino F
Prostaglandins; 1983 Mar; 25(3):343-51. PubMed ID: 6346397
[TBL] [Abstract][Full Text] [Related]
30. Effect of synthetic estrogen on platelet aggregation and vascular release of PGI2-like material in the rabbit.
Elam MB; Lipscomb GE; Chesney CM; Terragno DA; Terragno NA
Prostaglandins; 1980 Dec; 20(6):1039-51. PubMed ID: 7010445
[TBL] [Abstract][Full Text] [Related]
31. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
Bin Z; Kun L
Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
[TBL] [Abstract][Full Text] [Related]
32. Anti-platelet and anti-thrombotic effects of OP-41483.alpha-CD, a prostacyclin analogue, in experimental animals.
Katsube N; Sakaguchi K; Fujitani B; Aishita H
Prostaglandins Leukot Essent Fatty Acids; 1993 Oct; 49(4):795-804. PubMed ID: 8259376
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of renin release by 6-oxo-prostaglandin E1 and prostacyclin.
McGiff JC; Spokas EG; Wong PY
Br J Pharmacol; 1982 Jan; 75(1):137-44. PubMed ID: 7042021
[TBL] [Abstract][Full Text] [Related]
34. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
Wong PY; McGiff JC; Sun FF; Lee WH
Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
[TBL] [Abstract][Full Text] [Related]
35. An in vivo model for studying platelet aggregation and disaggregation.
Page CP; Paul W; Morley J
Thromb Haemost; 1982 Jun; 47(3):210-3. PubMed ID: 7051409
[TBL] [Abstract][Full Text] [Related]
36. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
37. Effects of PGI2 on platelet aggregation induced by various stimulants.
Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
[No Abstract] [Full Text] [Related]
38. The effect of prostacyclin (PGT2) on platelet behaviour. Thrombus formation in vivo and bleeding time.
Ubatuba FB; Moncada S; Vane JR
Thromb Haemost; 1979 Apr; 41(2):425-35. PubMed ID: 382434
[TBL] [Abstract][Full Text] [Related]
39. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.
McManus LM; Hanahan DJ; Pinckard RN
J Clin Invest; 1981 Mar; 67(3):903-6. PubMed ID: 7204562
[TBL] [Abstract][Full Text] [Related]
40. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
Parise LV; Venton DL; Le Breton GC
Thromb Res; 1982 Dec; 28(6):721-30. PubMed ID: 6301090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
